Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-30, Stock:JNJ, The news for the past five days is as follows:
2019-05-22: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Congo wants more use of Merck vaccine rather than J&J newcomer - minister.NEWS3: Ex-Dividend Reminder: Atmos Energy, Johnson & Johnson and Newmark Group.NEWS4: Ex-Dividend Reminder: Atmos Energy, Johnson & Johnson and Newmark Group.NEWS5: Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN.NEWS7: The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study.
2019-05-23: NEWS1: Health care recovery? 3 trades.NEWS2: The View from New Brunswick: Johnson & Johnson CEO Alex Gorsky at Healthy Returns.NEWS3: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS4: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS5: Better Buy: Johnson & Johnson vs. GlaxoSmithKline.NEWS6: Better Buy: Johnson & Johnson vs. GlaxoSmithKline.NEWS7: Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019.NEWS11: Better Buy: Johnson & Johnson vs. GlaxoSmithKline.NEWS12: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS13: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS14: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.
2019-05-24: NEWS1: Market Close Report: NASDAQ Composite index closes at 7,637.01 up 8.73 points.NEWS2: Market Close Report: NASDAQ Composite index closes at 7,637.01 up 8.73 points.NEWS3: XLV, SZNE: Big ETF Inflows.NEWS4: XLV, SZNE: Big ETF Inflows.NEWS5: iShares S&P 500 Value ETF Experiences Big Inflow.NEWS6: iShares S&P 500 Value ETF Experiences Big Inflow.NEWS7: 17 Monthly Dividends That Pay $2,629 Per Month.NEWS8: 17 Monthly Dividends That Pay $2,629 Per Month.NEWS9: Drug Makers&apos; Opioid Liability Tied to Untested Legal Theory.NEWS10: Dow 30 Stock Roundup: Home Depot Earnings Impress, Merck to Buy Peloton Therapeutics.NEWS11: Dow 30 Stock Roundup: Home Depot Earnings Impress, Merck to Buy Peloton Therapeutics.NEWS12: Health Care Sector Update for 05/24/2019: SURF, BMY, CELG, AXSM, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 05/24/2019: SURF, BMY, CELG, AXSM, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates.NEWS15: Dow 30 Stock Roundup: Home Depot Earnings Impress, Merck to Buy Peloton Therapeutics.
2019-05-28: NEWS1: 4 Drug and Health Stocks Pushing Higher &#160;.NEWS2: 4 Drug and Health Stocks Pushing Higher &#160;.NEWS3: Oklahoma attorney blames corporate greed for opioid crisis.NEWS4: Oklahoma attorney blames corporate greed for opioid crisis.NEWS5: Teva Plummets on Downgrade Following $85M Opioid Settlement.NEWS6: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS7: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS8: J&J's greed helped fuel U.S. opioid crisis, Oklahoma claims at trial.NEWS9: Trial underway in Oklahoma's lawsuit against opioid makers.NEWS10: The Latest: Drugmakers say products were heavily regulated.NEWS11: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS12: Trial begins in Oklahoma's lawsuit against opioid makers.NEWS13: 4 Drug and Health Stocks Pushing Higher.NEWS14: 9 Best Dividend Stocks to Buy for Every Investor.NEWS15: 9 Best Dividend Stocks to Buy for Every Investor.NEWS16: Oklahoma at trial says J&J's deceptive marketing fuelled U.S. opioid crisis.NEWS17: Oklahoma at trial says J&J's deceptive marketing fueled U.S. opioid crisis.NEWS18: Trial in Oklahoma's lawsuit against opioid makers underway.NEWS19: Factbox: Oklahoma becomes first U.S. state to take drugmaker to trial over opioids.NEWS20: Geron Stock Up More Than 50% in 2019 So Far: Here's Why.NEWS21: Geron Stock Up More Than 50% in 2019 So Far: Here's Why.NEWS22: First major opioid trial takes aim at pharmaceutical giant Johnson & Johnson.NEWS23: Oklahoma prosecutors blast J&J in first day of landmark opioid trial. State says drugmaker ran &apos;deceitful, multibillion-dollar brainwashing campaign&apos;.NEWS24: Oklahoma prosecutors blast J&J in first day of landmark opioid trial. State says drugmaker ran 'deceitful, multibillion-dollar brainwashing campaign'.NEWS25: J&J Stock Up This Year So Far: Will the Momentum Continue?.NEWS26: J&J Stock Up This Year So Far: Will the Momentum Continue?.NEWS27: Factbox: Oklahoma becomes first U.S. state to take drugmaker to trial over opioids.NEWS28: Geron Stock Up More Than 50% in 2019 So Far: Here's Why.NEWS29: Health Care Sector Update for 05/28/2019: TRXC, QTNT, BMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS30: Health Care Sector Update for 05/28/2019: TRXC, QTNT, BMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS31: J&J Stock Up This Year So Far: Will the Momentum Continue?.NEWS32: 2 Healthcare Stocks That Doubled Investors' Money in 2019.NEWS33: 2 Healthcare Stocks That Doubled Investors' Money in 2019.NEWS34: Here are the biggest analyst calls of the day: Beyond Meat, Apple, Southwest, Pfizer, Roku & more.NEWS35: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS36: 2 Healthcare Stocks That Doubled Investors&apos; Money in 2019.NEWS37: Oklahoma accuses Johnson & Johnson of fueling the opioid epidemic.NEWS38: The Pre-Markets Rundown: May 28, 2019.NEWS39: Oklahoma, Johnson & Johnson face off in first opioid crisis trial.
2019-05-29: NEWS1: It's Getting Emotional: Cramer's 'Mad Money' Recap (Wednesday 5/29/19).NEWS2: Time to slowly start buying into market weakness: Cramer.NEWS3: Jim Cramer: It's time to start buying amid market weakness, but take it slow.NEWS4: Jim Cramer: It&apos;s time to start buying amid market weakness, but take it slow.NEWS5: Jim Cramer: It's time to start buying amid market weakness, but take it slow.NEWS6: Dow Loses 221 Points Amid Trade, Treasury Anxieties.NEWS7: Dow Loses 221 Points Amid Trade, Treasury Anxieties.NEWS8: Buffett's Berkshire Hathaway Closes Below $300,000.NEWS9: U.S. football player's overdose death spotlighted in J&J Oklahoma opioid trial.NEWS10: Dow Jones Today: Trade War, Specter of Recession Are Toxic for Stocks.NEWS11: U.S. football player's overdose death spotlighted in J&J Oklahoma opioid trial.NEWS12: Market Close Report: NASDAQ Composite index closes at 7,547.31 down -60.04 points.NEWS13: Market Close Report: NASDAQ Composite index closes at 7,547.31 down -60.04 points.NEWS14: Capri, Abercrombie tumble; Marvell Technology rises.NEWS15: Johnson & Johnson Stock Falls as Its Opioid Trial Gets Underway.NEWS16: After Another Stock Market Sell-Off, Here&apos;s The Biggest Question For Investors.NEWS17: 4 Top Stock Trades for Thursday: DKS, LULU, XOM, JNJ.NEWS18: Noteworthy Wednesday Option Activity: DVA, JNJ, DE.NEWS19: Noteworthy Wednesday Option Activity: DVA, JNJ, DE.NEWS20: J&J Slide Deepens as Legal Woes Weigh on Shares Again.NEWS21: Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression.NEWS22: Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression.NEWS23: 10 Best Stocks to Buy and Hold Forever.NEWS24: 10 Best Stocks to Buy and Hold Forever.NEWS25: Should You Sell J&J Stock As Opioid Charges Heat Up?.NEWS26: Should You Sell J&J Stock As Opioid Charges Heat Up?.NEWS27: Band-Aids Cannot Help Johnson & Johnson in This Decline.NEWS28: Teva Settles With Oklahoma, Shares Fall Following Downgrade.NEWS29: Teva Settles With Oklahoma, Shares Fall Following Downgrade.NEWS30: Dow Movers: JNJ, INTC.NEWS31: Dow Movers: JNJ, INTC.NEWS32: Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression.NEWS33: Health Care Sector Update for 05/29/2019: SOLY, CARA, FCSC, JNJ, PFE, ABT, MRK, AMGN.NEWS34: Health Care Sector Update for 05/29/2019: SOLY, CARA, FCSC, JNJ, PFE, ABT, MRK, AMGN.NEWS35: States must lead the way in fight against opioid epidemic, says former Maryland attorney general.NEWS36: Teva Settles With Oklahoma, Shares Fall Following Downgrade.NEWS37: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 30, 2019.NEWS38: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 30, 2019.NEWS39: Should You Sell J&J Stock As Opioid Charges Heat Up?.NEWS40: Johnson & Johnson, Oklahoma come out swinging in first day of historic opioid trial.NEWS41: PRESS DIGEST- New York Times business news - May 29.NEWS42: Families impacted by the opioid crisis watching landmark trial.NEWS43: J&J's greed helped fuel U.S. opioid crisis, Oklahoma claims at trial.

Answer: Rise